Novel Method Based on Real-Time Cell Analysis for Drug Susceptibility Testing of Herpes Simplex Virus and Human Cytomegalovirus
Authors:
- 1 August 2016
- journal article
- research article
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 54 (8) , 2120-2127
Abstract
The plaque reduction assay (PRA) is the gold standard phenotypic method to determine herpes simplex virus (HSV) and human cytomegalovirus (HCMV) susceptibilities to antiviral drugs. However, this assay is subjective and labor intensive. Here, we describe a novel antiviral phenotypic method based on real-time cell analysis (RTCA) that measures electronic impedance over time. The effective drug concentrations that reduced by 50% (EC 50 s) the cytopathic effects induced by HSV-1 and HCMV were evaluated by both methods. The EC 50 s of acyclovir and foscarnet against a reference wild-type (WT) HSV-1 strain in Vero cells were, respectively, 0.5 μM and 32.6 μM by PRA and 0.8 μM and 93.6 μM by RTCA. The EC 50 ratios for acyclovir against several HSV-1 thymidine kinase (TK) mutants were 101.8×, 73.4×, 28.8×, and 35.4× (PRA) and 18.0×, 52.0×, 5.5×, and 87.8× (RTCA) compared to those for the WT. The EC 50 ratios for acyclovir and foscarnet against the HSV-1 TK/DNA polymerase mutant were 182.8× and 9.7× (PRA) and >125.0× and 10.8× (RTCA) compared to the WT. The EC 50 s of ganciclovir and foscarnet against WT HCMV strain AD169 in fibroblasts were, respectively, 1.6 μM and 27.8 μM by PRA and 5.0 μM and 111.4 μM by RTCA. The EC 50 ratios of ganciclovir against the HCMV UL97 mutant were 3.8× (PRA) and 8.2× (RTCA) compared to those for the WT. The EC 50 ratios of ganciclovir and foscarnet against the HCMV UL97/DNA polymerase mutant were 17.1× and 12.1× (PRA) and 14.7× and 4.6× (RTCA) compared to those for the WT. RTCA allows objective drug susceptibility testing of HSV and HCMV and could permit high-throughput screening of new antivirals.Keywords
Funding Information
- Gouvernement du Canada | Canadian Institutes of Health Research (MOP-142224)
This publication has 38 references indexed in Scilit:
- Evaluation of Impedance-Based Label-Free Technology as a Tool for Pharmacology and Toxicology InvestigationsBiosensors, 2013
- Comparative Analysis of Dynamic Cell Viability, Migration and Invasion Assessments by Novel Real-Time Technology and Classic Endpoint AssaysPLOS ONE, 2012
- Novel, Real-Time Cell Analysis for Measuring Viral Cytopathogenesis and the Efficacy of Neutralizing Antibodies to the 2009 Influenza A (H1N1) VirusPLOS ONE, 2012
- Real-time monitoring of flavivirus induced cytopathogenesis using cell electric impedance technologyJournal of Virological Methods, 2011
- Resistance of Herpes Simplex Viruses to Nucleoside Analogues: Mechanisms, Prevalence, and ManagementAntimicrobial Agents and Chemotherapy, 2011
- Antiviral Drug Resistance of Human CytomegalovirusClinical Microbiology Reviews, 2010
- Cellular impedance measurement as a new tool for poxvirus titration, antibody neutralization testing and evaluation of antiviral substancesBiochemical and Biophysical Research Communications, 2010
- Recombinant Phenotyping of Cytomegalovirus UL97 Kinase Sequence Variants for Ganciclovir ResistanceAntimicrobial Agents and Chemotherapy, 2010
- Conserved retinoblastoma protein-binding motif in human cytomegalovirus UL97 kinase minimally impacts viral replication but affects susceptibility to maribavirVirology Journal, 2009
- Thymidine Kinase Mutations Conferring Acyclovir Resistance in Herpes Simplex Type 1 Recombinant VirusesAntimicrobial Agents and Chemotherapy, 2006